Volulyte 6% 130/0.4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Volulyte 6% 130/0.4, covering 2015-04-24 to 2015-04-24. Get the full timeline:
Most recent: Clinical Trial Update: The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy [NA]